Emerik Osterlund

14PUBLICATIONS
68CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 02, 2026
Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

|Feb 03, 2026
Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO Study.

Joel Kontiainen, Kaisa Lehtomäki, Timo Muhonen

|Oct 21, 2025
KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts.

Emerik Osterlund, Ari Ristimäki, Luís Nunes

|Jul 02, 2025
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients.

Aparna Ganesan, Anttoni Korkiakoski, Simona Adamusová

|Aug 07, 2024
Prognostic genome and transcriptome signatures in colorectal cancers.

Luís Nunes, Fuqiang Li, Meizhen Wu

|Mar 13, 2024
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study).

Sonja Aho, Emerik Osterlund, Ari Ristimäki

Pageof 3

Frequent Collaborators

9 joint publications

Bengt Glimelius

5 joint publications

Pia Osterlund

4 joint publications

Kaisa Lehtomäki

4 joint publications

Aki Uutela